Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doreen Gruber

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Parkinsonism & Related Disorders|December 24, 2022
Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variantsTatiana Usnich, Maria Olmedillas, Nathalie Schell, et al.
Parkinsonism & Related Disorders|February 18, 2019
Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registryKirsten Haas, Stephanie Stangl, Frank Steigerwald, et al.
Journal of Parkinson'S Disease|June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathyLan Ye, Stephan Greten, Ida Wilkens, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2025
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease PatientsChristian A Ganoza, Ana Westenberger, Jefri J Paul, et al.
Frontiers in Neurology|September 3, 2021
LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic CohortTatiana Usnich, Eva-Juliane Vollstedt, Nathalie Schell, et al.
The New England Journal of Medicine|September 1, 2006
A randomized trial of deep-brain stimulation for Parkinson's diseaseGünther Deuschl, Carmen Schade-Brittinger, Paul Krack, et al.
Neurology|November 1, 2023
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson DiseaseDominik Pürner, Mohammad Hormozi, Daniel Weiß, et al.
Journal of Neurology|February 14, 2024
The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysisLan Ye, Stephan Greten, Florian Wegner, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Parkinsonism & Related Disorders|December 24, 2022
Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variantsTatiana Usnich, Maria Olmedillas, Nathalie Schell, et al.
Parkinsonism & Related Disorders|February 18, 2019
Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registryKirsten Haas, Stephanie Stangl, Frank Steigerwald, et al.
Journal of Parkinson'S Disease|June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathyLan Ye, Stephan Greten, Ida Wilkens, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2025
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease PatientsChristian A Ganoza, Ana Westenberger, Jefri J Paul, et al.
Frontiers in Neurology|September 3, 2021
LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic CohortTatiana Usnich, Eva-Juliane Vollstedt, Nathalie Schell, et al.
The New England Journal of Medicine|September 1, 2006
A randomized trial of deep-brain stimulation for Parkinson's diseaseGünther Deuschl, Carmen Schade-Brittinger, Paul Krack, et al.
Neurology|November 1, 2023
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson DiseaseDominik Pürner, Mohammad Hormozi, Daniel Weiß, et al.
Journal of Neurology|February 14, 2024
The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysisLan Ye, Stephan Greten, Florian Wegner, et al.
Pageof 5